American Society of Clinical Oncology 2013 Summary of Scientific Advancements in Gynecologic Cancer

被引：2

作者：

Eskander, Ramez N. ^{[1
]}

Tewari, Krishnansu S. ^{[1
]}

机构：

[1] Univ Calif Irvine, Dept Obstet & Gynecol, Div Gynecol Oncol, Orange, CA 92868 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 01期

基金：

美国国家卫生研究院;

关键词：

ASCO; 2013; Cervical cancer; Bevacizumab; Breast cancer; Ovarian cancer; Uterine cancer;

D O I：

10.1097/IGC.0000000000000030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The American Society of Clinical Oncology (ASCO) meeting was held in Chicago, Ill, from May 31, 2013, to June 4, 2013, and focused on Building Bridges to Conquer Cancer. An estimated 25,500 oncology professionals, with a broad range of interests, attended the meeting. Cervical cancer, a gynecologic malignancy with a significant global burden, was prominently featured at this year's meeting. In a mark of exemplary scientific accomplishment within our specialty, 2 of the 5 general session plenaries investigated advancements in cervical cancer care, extending from improved screening to treatment of metastatic disease. This was followed by the presentation of several important phase 2 and 3 clinical trials in the Gynecologic Oncology Tract, focusing on cervical, ovarian, uterine, and breast cancer, which will be discussed in this report.

引用

页码：13 / 18

页数：6